Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Grass Group 5 allergens are a family of highly potent and prevalent proteins found in the pollen of temperate grasses, such as timothy grass (*Phleum pratense*), ryegrass (*Lolium perenne*), and canary grass. These allergens are major triggers for allergic rhinitis (hay fever) and bronchial asthma, especially during the grass pollen season in temperate climates. They are characterized by ribonuclease activity and consist of isoforms such as Group 5a and Group 5b. Sensitization to Group 5 allergens is prevalent in a significant proportion of grass pollen-allergic individuals.
Allergen immunotherapy aims to induce tolerance by repeated exposure to the allergen, shifting the immune response from Th2 to Th1 and increasing IgG4 antibody production.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Grass Group 5 Allergen (Group 5 Allergen).